Glukosamin – den store sukkerpillebløffen

Key Words Dementia · Depression · Non-pharmacological treatment · Neuropsychiatric symptoms in dementia Abstract Background/Aims: A recent cluster-randomized controlled study

Methods Patient-reported sleep was a predefined secondary outcome in a prospective, randomized, placebo-controlled, double- blind trial that evaluated the analgesic efficacy

−-OSU6162 is a monoaminergic stabilizer affecting both neurotransmitter systems by acting antagonistically at the D2 dopamine receptor and partially agonistically on the

Therefore, within the setting of a randomized, double-blind, placebo-controlled longitudinal trial (rct) car- ried out to assess the effect of micronutrient supplementation in

A random- ized, double-blind, placebo-controlled, parallel- group, enriched-design study of nabiximols (Sati- vex), as add-on therapy, in subjects with refractory spasticity caused

A double-blinded, randomized, placebo- controlled trial to evaluate efficacy, safety and tolerability of single doses of tirasemtiv in patients with acetylcholine receptor

Consequently, the aim of the present study was to investigate the effect of pain treatment on sleep in NH patients with dementia and depression in a placebo ‐ controlled

Faecal microbiota transplantation versus placebo for moderate- to- severe irritable bowel syndrome: a double- blind, randomised, placebo- controlled, parallel- group, single-